As informações fornecidas no EL7.AI são apenas para fins educacionais e informativos e não constituem aconselhamento financeiro.

Urgentestocks

Cingulate Inc Shares Surge Following Key Patent Approval for ADHD Treatment

Detectado pela primeira vez: Mar 16, 2026, 5:47 PM

Última atualização: 8 days ago

8 artigos·8 notícias

Instrumentos Afetados

CING

Resumo do Evento

On March 16, the US Patent and Trademark Office (USPTO) approved a key patent application for Cingulate Inc's ADHD treatment. The patent protects the proprietary technology behind CTx-1301, the company's lead ADHD drug candidate. Following the announcement, Cingulate Inc shares surged in Monday morning trading.

Linha do tempo

Ciena Shares Surge as Analyst Upgrades Highlight Oracle Data Center Synergy

Mar 23, 2026, 10:31 PMImpact: 6

Sharp 8% Drop in Oil Prices Boosts Carvana Stock Performance

Mar 23, 2026, 8:04 PMImpact: 7

Planet Labs Shares Surge 15% on Record Earnings and AI-Driven Growth Outlook

Mar 20, 2026, 9:01 AMImpact: 6

Cingulate Inc Shares Surge Following Key Patent Approval for ADHD Treatment

Mar 16, 2026, 5:47 PMImpact: 7